SEC Tracker
Get the app

8-KBBOT

BridgeBio Oncology Therapeutics reports director resignation

Dr. Ben's resignation was not due to any disagreement with the Company's operations, policies, or practices.1

By SEC Tracker ·

BridgeBio Oncology TherapeuticsCIK 1869105Form 8-KFiled Nov 5, 2026, 4:01 PM ET0001193125-26-449722Read the filing on SEC.gov →

The Form 8-K includes the Company's signatures and confirms the report was duly authorized.2 No conflicts or disagreements were noted in the resignation.3

Key facts

Company
BridgeBio Oncology Therapeutics (BBOT)
CIK
1869105
Form
8-K
Items
5.02
Filed
Nov 5, 2026, 4:01 PM ET
Accession
0001193125-26-449722

From the EDGAR filing index, not written by AI.

How often BridgeBio Oncology Therapeutics files

Filings per calendar quarter, counted in code from the company's EDGAR filing list. Each bar splits 8-K current reports from other forms; the last bar is the quarter of this filing, counted up to it.

BridgeBio Oncology Therapeutics filings per quarter8-KOther formsSource: EDGAR filing list, counted in code02040608-K · Q1 25: 3Other forms · Q1 25: 8Other forms · Q2 25: 128-K · Q3 25: 4Other forms · Q3 25: 488-K · Q4 25: 1Other forms · Q4 25: 78-K · Q1 26: 3Other forms · Q1 26: 128-K · Q2 26: 4Other forms · Q2 26: 258-K · Q3 26: 2Other forms · Q3 26: 138-K · Q4 26: 1Other forms · Q4 26: 511125281529156Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
BridgeBio Oncology Therapeutics filings per quarter
The numbers
QuarterFilings8-K
Q1 25113
Q2 25120
Q3 25524
Q4 2581
Q1 26153
Q2 26294
Q3 26152
Q4 2661

Timeline

The company's filings on EDGAR around this one, newest first. Ownership forms and routine prospectus filings are left out.

  1. Form 8-KThis filing
  2. Form EFFECT
  3. Form EFFECT
  4. Form 8-K
  5. Form S-3
  6. Form POS AM

Get an email when BridgeBio Oncology Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Written with AI from the BridgeBio Oncology Therapeutics Form 8-K and checked against it sentence by sentence: each of the 3 numbered sentences opens the passage it comes from. AI can make mistakes. Check the filing. Not investment advice. Not affiliated with the U.S. SEC. Source filing on SEC.gov.

Data on this page was fetched . The filing on SEC.gov is the record.